Logo

Crossref


1. Pharmacological treatment options for metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review

- Laura A. M. Konings

- Lorena Miguelañez‐Matute

- Anna M. P. Boeren

- Inge A. T. van de Luitgaarden

- Femme Dirksmeier

- Rob J. de Knegt

- Maarten E. Tushuizen

- Diederick E. Grobbee

- Adriaan G. Holleboom

- Manuel Castro Cabezas